PT83530B - Processo de preparacao de derivados da piridona, em especial derivados fenilicos - Google Patents

Processo de preparacao de derivados da piridona, em especial derivados fenilicos

Info

Publication number
PT83530B
PT83530B PT83530A PT8353086A PT83530B PT 83530 B PT83530 B PT 83530B PT 83530 A PT83530 A PT 83530A PT 8353086 A PT8353086 A PT 8353086A PT 83530 B PT83530 B PT 83530B
Authority
PT
Portugal
Prior art keywords
derivatives
phenyler
preparation process
pyridone
pyridone derivatives
Prior art date
Application number
PT83530A
Other languages
English (en)
Other versions
PT83530A (en
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858525654A external-priority patent/GB8525654D0/en
Priority claimed from GB868601667A external-priority patent/GB8601667D0/en
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of PT83530A publication Critical patent/PT83530A/pt
Publication of PT83530B publication Critical patent/PT83530B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PT83530A 1985-10-17 1986-10-13 Processo de preparacao de derivados da piridona, em especial derivados fenilicos PT83530B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858525654A GB8525654D0 (en) 1985-10-17 1985-10-17 Chemical compounds
GB868601667A GB8601667D0 (en) 1986-01-23 1986-01-23 Chemical compounds

Publications (2)

Publication Number Publication Date
PT83530A PT83530A (en) 1986-11-01
PT83530B true PT83530B (pt) 1989-05-31

Family

ID=26289898

Family Applications (1)

Application Number Title Priority Date Filing Date
PT83530A PT83530B (pt) 1985-10-17 1986-10-13 Processo de preparacao de derivados da piridona, em especial derivados fenilicos

Country Status (16)

Country Link
US (2) US4906628A (pt)
EP (1) EP0220044B1 (pt)
CN (1) CN1009092B (pt)
AU (1) AU586042B2 (pt)
DE (1) DE3677316D1 (pt)
DK (1) DK491186A (pt)
ES (1) ES2031821T3 (pt)
FI (1) FI864193A7 (pt)
GR (1) GR3001555T3 (pt)
HU (1) HU196788B (pt)
IL (1) IL80296A (pt)
NO (1) NO864126L (pt)
NZ (1) NZ217931A (pt)
PH (1) PH22428A (pt)
PT (1) PT83530B (pt)
ZW (1) ZW20586A1 (pt)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962110A (en) * 1985-03-12 1990-10-09 Smith Kline & French Laboratories Limited Pyridazinone derivatives
GB8610369D0 (en) * 1986-04-28 1986-06-04 Smith Kline French Lab Heterocyclic compounds
GB8621864D0 (en) * 1986-09-11 1986-10-15 Smith Kline French Lab Chemical process
GB8901836D0 (en) * 1989-01-27 1989-03-15 Sobio Lab Compounds
DE3913597A1 (de) * 1989-04-25 1990-11-08 Heumann Pharma Gmbh & Co Diazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0482208B1 (en) * 1990-04-25 2000-07-19 Nissan Chemical Industries Ltd. Pyridazinone derivative
ATE180475T1 (de) * 1990-09-21 1999-06-15 Rohm & Haas Dihydropyridazinone und pyridazinone als fungizide
CN1038249C (zh) * 1991-08-28 1998-05-06 罗姆和哈斯公司 含有二氢哒嗪酮及其相关化合物的杀菌组合物
US5958926A (en) * 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
DE102004011512B4 (de) 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
EP1579862A1 (en) * 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
US7678363B2 (en) 2005-08-26 2010-03-16 Braincells Inc Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
EP2314289A1 (en) 2005-10-31 2011-04-27 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US8067433B2 (en) 2005-11-09 2011-11-29 Zalicus Inc. Methods, compositions, and kits for the treatment of ophthalmic disorders
CA2629367C (en) * 2005-11-14 2016-05-03 Boehringer Ingelheim Vetmedica Gmbh Use of pde iii inhibitors and/or calcium sensitizers for the treatment of asymptomatic (occult) heart failure
WO2007104035A1 (en) * 2006-03-08 2007-09-13 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
CA2651862A1 (en) * 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2377531A2 (en) 2006-05-09 2011-10-19 Braincells, Inc. Neurogenesis by modulating angiotensin
US7998971B2 (en) * 2006-09-08 2011-08-16 Braincells Inc. Combinations containing a 4-acylaminopyridine derivative
WO2008036678A2 (en) * 2006-09-19 2008-03-27 Braincells, Inc. Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
EP1920785A1 (en) * 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
AU2008261102B2 (en) 2007-06-04 2013-11-28 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP3239170B1 (en) 2008-06-04 2019-03-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
WO2010009319A2 (en) 2008-07-16 2010-01-21 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
EP2370070B9 (en) 2008-11-25 2014-04-23 Boehringer Ingelheim Vetmedica GmbH Pimobendan for use in the treatment of hypertrophic cardiomyopathy in cats.
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CA3100941C (en) 2011-03-01 2024-03-05 Synergy Pharmaceuticals Inc. Process of preparing guanylate cyclase c agonists
EP2804603A1 (en) 2012-01-10 2014-11-26 President and Fellows of Harvard College Beta-cell replication promoting compounds and methods of their use
EP2825159B1 (en) 2012-03-15 2022-06-22 Boehringer Ingelheim Vetmedica GmbH Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
WO2014131024A2 (en) 2013-02-25 2014-08-28 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
HRP20240805T1 (hr) 2013-06-05 2024-09-27 Bausch Health Ireland Limited Ultra-pročišćeni agonisti guanilat-ciklaze c, postupak njihove pripreme i uporabe
KR102455648B1 (ko) 2013-07-19 2022-10-19 베링거잉겔하임베트메디카게엠베하 보존된 에테르화된 사이클로덱스트린 유도체 함유 액체 수성 약제학적 조성물
CN114404588A (zh) 2013-08-09 2022-04-29 阿德利克斯公司 用于抑制磷酸盐转运的化合物和方法
EA034054B1 (ru) 2013-12-04 2019-12-23 Бёрингер Ингельхайм Ветмедика Гмбх Улучшенные фармацевтические композиции пимобендана
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
WO2019025554A1 (en) * 2017-08-04 2019-02-07 Bayer Aktiengesellschaft 6-PHENYL-4,5-DIHYDROPYRIDAZIN-3 (2H) -ONE DERIVATIVES AS INHIBITORS OF PDE3A AND PDE3B FOR THE TREATMENT OF CANCER
JOP20200024A1 (ar) 2017-08-04 2020-02-02 Bayer Ag مركبات ثنائي هيدروكساديازينون
WO2020157194A1 (en) 2019-02-01 2020-08-06 Bayer Aktiengesellschaft 1,2,4-triazin-3(2h)-one compounds for the treatment of hyperproliferative diseases
CN114340631A (zh) 2019-05-21 2022-04-12 阿德利克斯股份有限公司 用于降低患者的血清磷酸盐的组合
DE102021105255B4 (de) * 2021-03-04 2022-10-13 Festo Se & Co. Kg Vorrichtung mit über eine Verbindungsschnittstelle verbundenen Bauteilen und Verfahren zur Verbindung von Bauteilen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL69407A (en) * 1982-08-23 1987-10-20 Warner Lambert Co 2(1h)-pyridinones,their preparation and pharmaceutical compositions containing them
DE3600891A1 (de) * 1986-01-15 1987-07-16 Bayer Ag 1,8-verbrueckte 4-chinolon-3-carbonsaeuren und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
FI864193A0 (fi) 1986-10-16
EP0220044B1 (en) 1991-01-30
CN86106546A (zh) 1987-05-20
DE3677316D1 (de) 1991-03-07
DK491186A (da) 1987-04-18
CN1009092B (zh) 1990-08-08
EP0220044A3 (en) 1988-02-24
IL80296A (en) 1990-06-10
US4906628A (en) 1990-03-06
US5066653A (en) 1991-11-19
FI864193A7 (fi) 1987-04-18
EP0220044A2 (en) 1987-04-29
AU586042B2 (en) 1989-06-29
PT83530A (en) 1986-11-01
NO864126D0 (no) 1986-10-16
DK491186D0 (da) 1986-10-14
ZW20586A1 (en) 1988-05-25
PH22428A (en) 1988-09-12
HU196788B (en) 1989-01-30
NO864126L (no) 1987-04-21
NZ217931A (en) 1989-04-26
GR3001555T3 (en) 1992-11-23
HUT41769A (en) 1987-05-28
ES2031821T3 (es) 1993-01-01
AU6416686A (en) 1987-04-30

Similar Documents

Publication Publication Date Title
PT83530B (pt) Processo de preparacao de derivados da piridona, em especial derivados fenilicos
PT83608B (pt) Processo de preparacao de derivados da paroxetina
PT83643B (pt) Processo de preparacao de derivados de quinoleina
FI870582A7 (fi) Aminouretaaneja, niiden valmistusmenetelmä ja niiden käyttö
FI884947A7 (fi) Tetrahydro-furo- ja -tieno/2,3-c/pyridiinit, niiden käyttö lääkeaineina ja menetelmä niiden valmistamiseksi
FI871419A7 (fi) Kinoliini-3-karboksyylihappojohdannaiset, niiden valmistus ja käyttö
BR8602293A (pt) Processo catalitico de preparacao 1,4-cispolibutadieno
SE8600668D0 (sv) 4-substituted androstendione derivatives and process for their preparation
BR8605210A (pt) Processos para a preparacao de piridina-2,3-dicarboxilatos substituidos e di-substituidos e processo para a preparacao de nicotinatos substituidos
BR8606968A (pt) Perfluoropolieteres e processo de preparacao dos mesmos
PT83451B (pt) Processo para a preparacao de derivados de quinolina, benzotiazole e seus analogos
PT91098A (pt) Processo de preparacao de derivados de (aza)naftalenossultame
FI860878A7 (fi) Aminohappojohdokset ja menetelmä niiden valmistamiseksi.
FI861987L (fi) Piperidylideeni dihydrodibentso/a,d/syklohepteenien ja niiden atsajohdosten valmistusmenetelmä
BR8603592A (pt) Derivados de piridazinona,processo para sua preparacao,e composicoes inseticidas
FI892675A7 (fi) 2,6-dihalogeenipyridiini-3-karboksyylihappojohdannaiset ja niiden valmistus
FI860556A7 (fi) Uusia 1,8-naftyridiinijohdannaisia ja niiden valmistusmenetelmä.
PT81433B (pt) Processo de preparacao de comestico anti-rugas
DK9887A (da) Pyridinderivater
FI853698A7 (fi) Pyrimidiinijohdokset, menetelmä niiden valmistamiseksi ja näiden seokset.
FI850266A7 (fi) Atsolyyliaryylialkanolijohdoksia, menetelmä niiden valmistamiseksi ja niiden käyttö.
PT92605A (pt) Processo de preparacao de derivados da 2-imino-6-polifluoroalcoxibenzotiazolina
DK46287A (da) Pyridinderivater
KR860005814A (ko) 1,6-나프티리딘-2(1h)-온 및 그의 제조방법
MA20660A1 (fr) Derives de nitrofuranne, leur preparation et leur application

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19940531